Cargando…

Graves' disease complicated by concurrent thyroid eye disease and pretibial myxedema successfully treated with teprotumumab

We report a 51‐year‐old woman with thyroid eye disease and biopsy‐proven pretibial myxedema that was subsequently treated with teprotumumab with improvement.

Detalles Bibliográficos
Autores principales:	Bowens, Brendan K., Chou, Eva, LaChance, David P., Huynh, James R., Voorhees, Patrick, Do, Thanh C., Shakir, Mohamed K. M., Hoang, Thanh D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9675368/ https://www.ncbi.nlm.nih.gov/pubmed/36415714 http://dx.doi.org/10.1002/ccr3.6621

Ejemplares similares

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

Resolution of pretibial myxedema with teprotumumab in a patient with Graves disease
por: Varma, Aakaash, et al.
Publicado: (2020)

Teprotumumab for Treatment of Pretibial Myxedema
por: Reyes, Michelangelo P, et al.
Publicado: (2023)

A case of pretibial myxedema treated with teprotumumab
por: Petit, Lauren, et al.
Publicado: (2021)

FRI554 Pretibial Myxedema Associated With Hashimoto Thyroiditis Treated With Teprotumumab
por: Marta Niedzialkowska, Ewelina, et al.
Publicado: (2023)

Worsening of pretibial myxedema following radioiodine treatment for hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2023)

Rapidly progressive cognitive decline associated with teprotumumab in thyroid eye disease
por: Hoang, Thanh Duc, et al.
Publicado: (2021)

Rapidly Progressive Cognitive Decline and Varicella Zoster Blisters Associated With Teprotumumab in 2 Patients With Graves’ Orbitopathy
por: Hoang, Thanh Duc, et al.
Publicado: (2021)

SAT-471 A Rare Case of Pretibial Myxedema Preceding Graves’ Hyperthyroidism
por: Bao, Ginny W, et al.
Publicado: (2020)

Pretibial Myxedema Presenting as Severe Elephantiasis
por: Lee, Jae-Hoon, et al.
Publicado: (2018)

SAT199 Intrathyroidal Parathyroid Adenomas: A Case Series
por: Bowens, Brendan K, et al.
Publicado: (2023)

ODP502 Nodular Pretibial Myxedema without Graves’ Orbitopathy: A Case Report
por: Veeramachaneni, Ravali, et al.
Publicado: (2022)

Treatment of pretibial myxedema with intralesional immunomodulating therapy
por: Ren, Ziwei, et al.
Publicado: (2017)

Pretibial myxedema successfully treated with intralesional hyaluronidase
por: Hoesly, Paul M., et al.
Publicado: (2018)

Elephantiasic Pretibial Myxedema with Involvement of the Buttocks and Face
por: Wang, Ya-Nan, et al.
Publicado: (2017)

Pretibial myxedema treated with intralesional hyaluronidase and triamcinolone
por: Kudlak, Natalie, et al.
Publicado: (2020)

ODP531 Worsening of pretibial myxedema following repeated doses of radioiodine treatment in a patient with hyperthyroid Graves’ disease
por: Thewjitcharoen, Yotsapon, et al.
Publicado: (2022)

Rituximab therapy for a severe case of pretibial myxedema
por: Jimenez, Amber, et al.
Publicado: (2021)

SUN-576 Abrupt Switching From Hypertyroidism To Hypothyroidism With Pretibial Myxedema And Acropachy, In Graves’ Ophthalmopathy: Case Report.
por: Ferreira, Eduardo, et al.
Publicado: (2019)

Successful therapeutic approach in a patient with elephantiasic pretibial myxedema()()
por: Ferreira, Marina, et al.
Publicado: (2020)

Pretibial myxedema in a euthyroid patient: a case report
por: Ambachew, Rediet, et al.
Publicado: (2021)

Pretibial myxedema in a patient with HIV and hypothyroid to hyperthyroid transformation
por: Chen, Maggie, et al.
Publicado: (2023)

A Randomized Controlled Trial of Intralesional Glucocorticoid for Treating Pretibial Myxedema
por: Lan, Changgui, et al.
Publicado: (2015)

Teprotumumab: a disease modifying treatment for graves’ orbitopathy
por: Ting, Michelle, et al.
Publicado: (2020)

Intralesional and topical glucocorticoids for pretibial myxedema: A case report and review of literature
por: Zhang, Fan, et al.
Publicado: (2018)

An atypical presentation of pretibial myxedema in a euthyroid patient with absent antithyroid autoantibodies
por: Beaulieu, Derek, et al.
Publicado: (2021)

A Case of Elephantiasic Pretibial Myxedema Successfully Treated With Intralesional Triamcinolone Acetate
por: Hathi, Deep, et al.
Publicado: (2022)

SAT461 Hearing-related Issues Associated With Graves’ Disease, Thyroid Eye Disease And Treatment With Teprotumumab
por: Smith, Terry J, et al.
Publicado: (2023)

Local immune microenvironment of skin may play an important role in the development of pretibial myxedema
por: Chen, Xiaoying, et al.
Publicado: (2021)

Mixedema pretibial en enfermedad de Graves
por: Tomás-Velázquez, Alejandra, et al.
Publicado: (2019)

Efficacy and Safety of Teprotumumab in Thyroid Eye Disease
por: Teo, Honeylen Maryl, et al.
Publicado: (2021)

Teprotumumab in advanced reactivated thyroid eye disease
por: Cheng, Olivia T., et al.
Publicado: (2022)

Improvement of asymmetric thyroid eye disease with teprotumumab
por: Ugradar, Shoaib, et al.
Publicado: (2022)

Teprotumumab for the treatment of chronic thyroid eye disease
por: Ugradar, Shoaib, et al.
Publicado: (2021)

Teprotumumab: A Review in Thyroid Eye Disease
por: Nie, Tina, et al.
Publicado: (2022)

MON-249 SDHD Mutation: Nonfunctional Paragangliomas Presenting as Bilateral Carotid Body Tumors with Syncope
por: LaChance, David, et al.
Publicado: (2020)

Early experience with teprotumumab for chronic thyroid eye disease
por: Ozzello, Daniel J., et al.
Publicado: (2020)

Teprotumumab and the Evolving Therapeutic Landscape in Thyroid Eye Disease
por: Kossler, Andrea Lora, et al.
Publicado: (2022)

Correction: Teprotumumab: A Review in Thyroid Eye Disease
por: Nie, Tina, et al.
Publicado: (2022)

Clinical picture: SDHD paraganglioma presenting with syncope
por: LaChance, David P., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_91flnsrv8b6l3h8ec8sgh5ls65